These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20145418)

  • 1. Neuroprotection in diabetic encephalopathy.
    Fazeli SA
    Neurodegener Dis; 2009; 6(5-6):213-8. PubMed ID: 20145418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glabridin as a major active isoflavan from Glycyrrhiza glabra (licorice) reverses learning and memory deficits in diabetic rats.
    Hasanein P
    Acta Physiol Hung; 2011 Jun; 98(2):221-30. PubMed ID: 21616781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and cognitive impairment: how to evaluate the cognitive status?
    Pasquier F
    Diabetes Metab; 2010 Oct; 36 Suppl 3():S100-5. PubMed ID: 21211730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences.
    Kuhad A; Chopra K
    Eur J Pharmacol; 2007 Dec; 576(1-3):34-42. PubMed ID: 17822693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of hemoglobin vesicles during cardiopulmonary bypass priming prevents neurocognitive decline in rats.
    Yamazaki M; Aeba R; Yozu R; Kobayashi K
    Circulation; 2006 Jul; 114(1 Suppl):I220-5. PubMed ID: 16820576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of episodic and working memory impairments on semantic and cognitive procedural learning at alcohol treatment entry.
    Pitel AL; Witkowski T; Vabret F; Guillery-Girard B; Desgranges B; Eustache F; Beaunieux H
    Alcohol Clin Exp Res; 2007 Feb; 31(2):238-48. PubMed ID: 17250615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats.
    Lupien SB; Bluhm EJ; Ishii DN
    J Neurosci Res; 2003 Nov; 74(4):512-23. PubMed ID: 14598295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of treadmill running on spatial learning and memory in streptozotocin-induced diabetic rats.
    Reisi P; Alaei H; Babri S; Sharifi MR; Mohaddes G
    Neurosci Lett; 2009 May; 455(2):79-83. PubMed ID: 19368850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes.
    Sima AA; Kamiya H; Li ZG
    Eur J Pharmacol; 2004 Apr; 490(1-3):187-97. PubMed ID: 15094085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacotherapy of the cognitive sequelae secondary to traumatic brain injury].
    Riós-Romenets S; Castaño-Monsalve B; Bernabeu-Guitart M
    Rev Neurol; 2007 Nov 1-15; 45(9):563-70. PubMed ID: 17979087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) reduces hippocampal damage but fails to prevent learning and memory deficits after transient, global cerebral ischemia in rats.
    Benetoli A; Dutra AM; Paganelli RA; Senda DM; Franzin S; Milani H
    Pharmacol Biochem Behav; 2007 Nov; 88(1):28-38. PubMed ID: 17675223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular cognitive impairment. A preventable cause of dementia.
    Mayo Clin Womens Healthsource; 2008 Dec; 12(12):4-5. PubMed ID: 18985021
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression changes of growth-associated protein-43 (GAP-43) and mitogen-activated protein kinase phosphatase-1 (MKP-1) and in hippocampus of streptozotocin-induced diabetic cognitive impairment rats.
    Zhou J; Wang L; Ling S; Zhang X
    Exp Neurol; 2007 Aug; 206(2):201-8. PubMed ID: 17601561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis.
    Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in cognitive functioning in the brain-damaged patient.
    Mahoney EK
    Nurs Clin North Am; 1980 Jun; 15(2):283-92. PubMed ID: 6902898
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury.
    Saatman KE; Contreras PC; Smith DH; Raghupathi R; McDermott KL; Fernandez SC; Sanderson KL; Voddi M; McIntosh TK
    Exp Neurol; 1997 Oct; 147(2):418-27. PubMed ID: 9344566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycopene attenuates diabetes-associated cognitive decline in rats.
    Kuhad A; Sethi R; Chopra K
    Life Sci; 2008 Jul; 83(3-4):128-34. PubMed ID: 18585396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes, aging, and cognitive decline.
    Ryan CM
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():21-5. PubMed ID: 16213627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats.
    Peng Y; Xu S; Chen G; Wang L; Feng Y; Wang X
    J Pharmacol Exp Ther; 2007 Jun; 321(3):902-10. PubMed ID: 17374747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels.
    Brands AM; Kessels RP; de Haan EH; Kappelle LJ; Biessels GJ
    Eur J Pharmacol; 2004 Apr; 490(1-3):159-68. PubMed ID: 15094082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.